Baystate Wealth Management LLC Abb Vie Inc. Transaction History

Baystate Wealth Management LLC

$1.36 Billion
Q4 2023

A detailed history of Baystate Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Baystate Wealth Management LLC holds 5,011 shares of ABBV stock, worth $878,829. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,011

Previous 4,297 16.62%

Holding current value

$878,829

Previous $640,000 21.25%

% of portfolio

0.06%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $98,246 - $110,648	714 Added 16.62%	5,011 $776,000
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $30,057 - $34,796	225 Added 5.53%	4,297 $640,000
Q2 2023 Sep 21, 2023	SELL	$132.51 - $164.9 $1.08 Million - $1.35 Million	-8,184 Reduced 66.78%	4,072 $548,000
Q2 2023 Aug 02, 2023	BUY	$132.51 - $164.9 $1.05 Million - $1.3 Million	7,904 Added 181.62%	12,256 $1.65 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $19,233 - $22,149	133 Added 3.15%	4,352 $693,000
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $11,064 - $13,269	-80 Reduced 1.86%	4,219 $682,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $4,697 - $5,387	35 Added 0.82%	4,299 $577,000
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $9,358 - $11,897	-68 Reduced 1.57%	4,264 $653,000
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $8,842 - $10,971	-67 Reduced 1.52%	4,332 $702,000
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $42,864 - $54,236	399 Added 9.98%	4,399 $596,000
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $30,536 - $34,663	287 Added 7.73%	4,000 $432,000
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $20,831 - $23,207	198 Added 5.63%	3,713 $418,000
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $3,171 - $3,491	31 Added 0.89%	3,515 $380,000
Q4 2020 Jan 15, 2021	SELL	$80.49 - $108.67 $118,400 - $159,853	-1,471 Reduced 29.69%	3,484 $373,000
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $22,852 - $26,820	266 Added 5.67%	4,955 $434,000
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $30,962 - $41,431	422 Added 9.89%	4,689 $460,000
Q1 2020 Apr 22, 2020	BUY	$64.5 - $97.79 $1,612 - $2,444	25 Added 0.59%	4,267 $325,000
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $63,546 - $79,510	881 Added 26.21%	4,242 $376,000
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $45,219 - $54,366	-718 Reduced 17.6%	3,361 $254,000
Q2 2019 Jul 02, 2019	BUY	$65.7 - $83.98 $1,839 - $2,351	28 Added 0.69%	4,079 $299,000
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $16,045 - $18,884	-208 Reduced 4.88%	4,051 $319,000
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $2,101 - $2,592	27 Added 0.64%	4,259 $381,000
Q3 2018 Oct 16, 2018	BUY	$88.91 - $98.84 $36,453 - $40,524	410 Added 10.73%	4,232 $394,000
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $1,795 - $2,124	20 Added 0.53%	3,822 $363,000
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $265,569 - $339,214	3,802	3,802 $345,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.

Account

Baystate Wealth Management LLC Abb Vie Inc. Transaction History